FIELD: pharmacy.
SUBSTANCE: invention relates to a pharmaceutical composition based on a palladium compound. The composition comprises palladium acidocomplexe of the formula: (C5H12NO)2[PDCI4] at a concentration of 0.2% in 0.9% sodium chloride aqueous solution.
EFFECT: antitumor and antimetastatic action at course parenteral administration of effective doses.
5 cl, 13 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ENHANCING OF CYCLOPHOSPHAN ANTITUMOR AND ANTIMETASTATIC ACTIVITY IN EXPERIMENT | 2004 |
|
RU2270682C2 |
CATION-ANIONIC COMPLEXES OF PALLADIUM | 2018 |
|
RU2699809C1 |
PEPTIDE, POSSESSING ANTI-TUMOR AND ANTI-METASTATIC ACTIVITY, AND FINISHED DOSAGE FORM BASED THEREON | 2018 |
|
RU2682039C1 |
SPECIFIC COMBINED THERAPY OF MALIGNANT TUMOURS WITH CYTOSTATIC AGENT AND ITS MODIFYING AGENT | 2015 |
|
RU2571551C1 |
MEANS FOR ANTIMETASTATIC ACTIVITY AND IMPROVED ANTIMETASTATIC ACTION OF CYCLOPHOSPHANE | 2016 |
|
RU2657602C1 |
NEW 9-AMINOACRIDONE DERIVATIVE WITH ANTITUMOR AND ANTIMETASTATIC ACTIVITY | 2021 |
|
RU2810783C2 |
METHOD OF TREATING EXPERIMENTAL 3,4-BENZ(α)PYRENE INDUCED TUMOURS IN SPLENECTOMISED ANIMALS | 2011 |
|
RU2474430C1 |
2-AMINOCHROMEN DERIVATIVES EXHIBITING ANTI-TUMOR ACTIVITY; PHARMACEUTICAL COMPOSITIONS | 2018 |
|
RU2704262C1 |
METHOD FOR CREATING BIOLOGICAL MODEL OF MODERATE GROWTH INHIBITION OF TUMOUR AND METASTASES IN LEWIS LUNG CARCINOMA WITH PROLONGED CYCLOPHOSPHANINE-INDUCED LEUKOPENIA IN MICE | 2012 |
|
RU2488173C1 |
ANTIMETASTATIC COMPOSITION | 2006 |
|
RU2308966C1 |
Authors
Dates
2017-03-15—Published
2015-08-04—Filed